Literature DB >> 16204248

TIS7 regulation of the beta-catenin/Tcf-4 target gene osteopontin (OPN) is histone deacetylase-dependent.

Ilja Vietor1, Robert Kurzbauer, Gerald Brosch, Lukas A Huber.   

Abstract

12-O-Tetradecanoylphorbol-13-acetate-induced sequence 7 (TIS7) acts as a transcriptional co-repressor interacting with SIN3, the histone deacetylase-containing complex. The overexpression of TIS7 down-regulates expression of a specific set of genes. Homozygous deletion of this gene in mice delays injury-induced muscle regeneration and inhibits muscle satellite cell differentiation and fusion of myoblasts in vitro. Osteopontin (OPN), a known beta-catenin/T cell factor-4 (Tcf-4) downstream target gene, is up-regulated in tumors and in cells with increased motility such as muscle cells. OPN promoter sequence contains binding sites for Sp1, glucocorticoid receptor, E-box-binding factors, octamer motif-binding protein, c-Myc, and other transcription factors. Previously we have shown that TIS7 regulates the OPN expression through the inhibition of the Sp1-activating effects. Here we show that TIS7 has the capacity to inhibit OPN expression also through Lef-1, the second identified OPN regulatory element. TIS7 has the capacity to down-regulate beta-catenin/Tcf-4 transcriptional activity. TIS7 homologous deletion in mouse embryonic fibroblasts increased not only the TOPflash reporter gene transcriptional activity but also the expression of c-Myc and OPN. Furthermore, we show that TIS7 overexpression leads to the beta-catenin interaction with enzymatically active histone deacetylases. We propose that TIS7 down-regulates the beta-catenin/Tcf-4 transcriptional activity via its interaction with histone deacetylase-containing complex thereby inhibiting the expression of beta-catenin downstream target genes such as c-Myc and OPN. We hypothesize that TIS7 as a negative regulator of transcriptional activity represses expression of OPN and beta-catenin/Tcf-4 target genes, which are involved in myogenesis, muscle maintenance, and regeneration in a histone deacetylase dependent manner.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16204248     DOI: 10.1074/jbc.M509836200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  10 in total

1.  Stress-sensitive regulation of IFRD1 mRNA decay is mediated by an upstream open reading frame.

Authors:  Chenyang Zhao; Shyamasree Datta; Palash Mandal; Shuqing Xu; Thomas Hamilton
Journal:  J Biol Chem       Date:  2010-01-15       Impact factor: 5.157

2.  Apc(MIN) modulation of vitamin D secosteroid growth control.

Authors:  Haibo Xu; Gary H Posner; Michael Stevenson; Frederick C Campbell
Journal:  Carcinogenesis       Date:  2010-05-20       Impact factor: 4.944

3.  Deletion of Tis7 protects mice from high-fat diet-induced weight gain and blunts the intestinal adaptive response postresection.

Authors:  Cong Yu; Shujun Jiang; Jianyun Lu; Carrie C Coughlin; Yuan Wang; Elzbieta A Swietlicki; Lihua Wang; Ilja Vietor; Lukas A Huber; Domagoj Cikes; Trey Coleman; Yan Xie; Clay F Semenkovich; Nicholas O Davidson; Marc S Levin; Deborah C Rubin
Journal:  J Nutr       Date:  2010-09-22       Impact factor: 4.798

4.  The Role of the O-GlcNAc Modification in Regulating Eukaryotic Gene Expression.

Authors:  Sandii Brimble; Edith E Wollaston-Hayden; Chin Fen Teo; Andrew C Morris; Lance Wells
Journal:  Curr Signal Transduct Ther       Date:  2010

5.  IFRD1 polymorphisms and gastric cancer risk in a Chinese population.

Authors:  Rui Xu; Changbing Peng; Shuomeng Xiao; Wen Zhuang
Journal:  Med Oncol       Date:  2014-07-30       Impact factor: 3.064

6.  TIS7 induces transcriptional cascade of methylosome components required for muscle differentiation.

Authors:  Andrea Lammirato; Katherin Patsch; Fabien Feiereisen; Karl Maly; Charity Nofziger; Markus Paulmichl; Hubert Hackl; Zlatko Trajanoski; Taras Valovka; Lukas A Huber; Ilja Vietor
Journal:  BMC Biol       Date:  2016-10-25       Impact factor: 7.431

7.  Identification of osteopontin-dependent signaling pathways in a mouse model of human breast cancer.

Authors:  Zhiyong Mi; Hongtao Guo; Paul C Kuo
Journal:  BMC Res Notes       Date:  2009-07-01

8.  Endosomal adaptor proteins APPL1 and APPL2 are novel activators of beta-catenin/TCF-mediated transcription.

Authors:  Sajid Rashid; Iwona Pilecka; Anna Torun; Marta Olchowik; Beata Bielinska; Marta Miaczynska
Journal:  J Biol Chem       Date:  2009-05-11       Impact factor: 5.157

9.  SOX9 is a novel cancer stem cell marker surrogated by osteopontin in human hepatocellular carcinoma.

Authors:  Takayuki Kawai; Kentaro Yasuchika; Takamichi Ishii; Yuya Miyauchi; Hidenobu Kojima; Ryoya Yamaoka; Hokahiro Katayama; Elena Yukie Yoshitoshi; Satoshi Ogiso; Sadahiko Kita; Katsutaro Yasuda; Ken Fukumitsu; Junji Komori; Etsuro Hatano; Yoshiya Kawaguchi; Shinji Uemoto
Journal:  Sci Rep       Date:  2016-07-26       Impact factor: 4.379

10.  The β-catenin/TCF-4 pathway regulates the expression of OPN in human osteoarthritic chondrocytes.

Authors:  Jian Tian; Shu-Guang Gao; Yu-Sheng Li; Chao Cheng; Zhen-Han Deng; Wei Luo; Fang-Jie Zhang
Journal:  J Orthop Surg Res       Date:  2020-08-20       Impact factor: 2.359

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.